We noted in the November 18 issue1 that Dr. Vera Price, theauthor of a Drug Therapy article published in the September23 issue,2 had received major research support through her universityfrom companies that manufactured drugs discussed in her articleand that she had recently consulted for those companies. Althoughshe informed us of these arrangements at the time her articlewas solicited, we failed to respond in accordance with our conflict-of-interestpolicy, which would have disqualified her. Because of the inconsistencybetween our stated policy and practice in this case, we reviewedthe files and spoke with the . . . [Full Text of this Article]
Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T.
(2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS
88: 1650-1663
[Full Text]
Levine, M. M, Campbell, J. D, Kotloff, K. L
(2002). Overview of vaccines and immunisation. Br Med Bull
62: 1-13
[Full Text]
Ehrle, L. H., Lempert, P., Thier, S. O., Gelijns, A. C.
(2002). Partnerships Between Universities and Industry. JAMA
287: 1398-1400
[Full Text]
McCrary, S. V., Anderson, C. B., Jakovljevic, J., Khan, T., McCullough, L. B., Wray, N. P., Brody, B. A.
(2000). A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research. NEJM
343: 1621-1626
[Abstract][Full Text]
Boyd, E. A., Bero, L. A.
(2000). Assessing Faculty Financial Relationships With Industry: A Case Study. JAMA
284: 2209-2214
[Abstract][Full Text]
McMasters, K. M., Recker, R. R., Goldberg, B., Angell, M., Utiger, R. D., Wood, A. J.J.
(2000). Disclosure of Authors' Conflicts of Interest -- A Follow-Up. NEJM
343: 146-147
[Full Text]
Rennie, D., Luft, H. S.
(2000). Pharmacoeconomic Analyses: Making Them Transparent, Making Them Credible. JAMA
283: 2158-2160
[Full Text]